LC

Lily Chang

Vice President at Novo Holdings

San Francisco, California

Overview 

Lily Chang is an Investor on the Novo Holdings Growth Team in San Francisco, specializing in Series B investments across various sectors like diagnostics, digital health, and FinTech. With a background in healthcare venture capital and consulting, she has held roles at HealthQuest Capital, Kaiser Permanente Ventures, and L.E.K. Consulting, demonstrating expertise in data analysis and leadership.

Work Experience 

  • Vice President

    2024 - Current

  • Senior Associate

    2022 - 2024

  • Associate

    2021 - 2022

    https://www.healthquestcapital.com/

HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry

  • Associate

    2021 - 2021

    https://www.kpventures.com/

  • Commercial Operations Manager

    2018 - 2021

    2019-20 Role based in London, UK 2018-19 Role based in Redwood City, California

HeartFlow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Raised $792,722,908.00 from Baillie Gifford, Janus Henderson Investors, Hayfin Capital Management, HealthCor Partners, U.S. Venture Partners, Martis Capital, Wellington Management, Bain Capital Life Sciences and Capricorn Investment Group.

  • Associate Consultant

    2014 - 2018

    Associate Consultant (2017-2018) | London, UK Associate (2015-2017) | Chicago, IL Summer associate (2014) | Chicago, IL

  • HyperCare Analyst

    2013 - 2014

AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.

Raised $15,000,249,999.00.

  • Manufacturing Intern

    2012 - 2014

The Clara Abbott Foundation is a non-profit firm aimed to assist families, in gaining financial security for the rest of their lives.

Articles About Lily

Relevant Websites